
Cabaletta Bio Inc
100%
Employees say this is a great place to work
Company Overview
About The Company
Cabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. We went public in October of 2019, and as of July 2020, have 31 employees.
COMPANY SIZE
31 U.S.-based Employees
(Small)
INDUSTRY
Biotechnology & Pharmaceuticals
HQ Location
Philadelphia, PA, US
Employee Demographics
Generation
Tenure
Company Culture at Cabaletta Bio Inc
The employee experience below at Cabaletta Bio Inc, compared to a typical U.S. based company.
Learn More100% of employees at Cabaletta Bio Inc say it is a great place to work compared to 59% of employees at a typical U.S.-based company.
Source: Great Place to Work® 2019 U.S. National Employee Engagement Study.
100%
Management is approachable, easy to talk with.
100%
People here are given a lot of responsibility.
100%
Management delivers on its promises.
100%
Management's actions match its words.
100%
I believe management would lay people off only as a last resort.
Why Work at Cabaletta Bio Inc?
See what employees say about what makes Cabaletta Bio Inc a great workplace. These words are drawn from employee comments on the Trust Index™ survey.
Life at Cabaletta Bio Inc
Don't See Your Company Listed?
Nominate your company today to join Certification Nation

CONNECT